期刊文献+

91例混合性结缔组织病患者的临床特点及转归 被引量:16

Analysis of clinical features and the outcome in 91 cases of mixed connective tissue diseases
下载PDF
导出
摘要 目的:了解混合性结缔组织病(mixed connective tissue disease,MCTD)的临床特点及其转归。方法:回顾性分析1990年至2008年在北京大学人民医院风湿免疫科收治的91例MCTD患者,分析其临床表现、实验室检查及临床辅助检查特点,并对其进行随访,依据其不同转归结果进行分组比较。结果:MCTD患者首诊时雷诺现象、关节痛、关节炎、发热、乏力、抗核抗体(antinuclear antibodies,ANA)阳性和抗核糖核蛋白抗体(ribosenuclear protein an-tibodies,RNP)阳性的发生率高。91例患者中有63例完成随访,死亡6例,失访22例。63例MCTD患者经过1~6年随访,8例明确诊断为系统性红斑狼疮(systemiclupuserythematosus,SLE),2例为抗中性粒细胞胞浆抗体(anti-neu-trophil cytoplasmic antibodyes,ANCA)相关性小血管炎(ANCA-associated vasculitis,AAV),2例为类风湿关节炎(rheumatoid arthritis,RA),1例为原发性干燥综合征(primary Sjgren’s syndrome,pSS),50例仍为MCTD。发展为SLE的患者发病初期脱发,蛋白尿,血小板下降,低补体血症的发生率较高。结论:MCTD可发展为明确的自身免疫性疾病,其转归与发病时的临床特点有关。 Objective:To investigate the clinical features and prognosis of mixed connective tissue disease(MCTD).Methods: Clinical,laboratory and instrumental examination information of 91 patients with MCTD,who were diagnosed between 1990 to 2008 in Peking University People's Hospital,were collected and analyzed retrospectively.These patients were following-up,and different outcoms compared.Results: The most common manifestations of MCTD patients were Raynaud phenomenon,arthralgia,arthritis,fever,acratia,positivities of antinuclear antibodies(anti-ANA) and ribosenuclear protein antibodies(anti-RNP),which were 94.5%,78%,46.2%,48.4%,53.9%,100% and 100%,respectively.Six patients died,and 22 patients were lost in the follow-up after discharge.Among the remaining 63 patients,8 developed into systemic lupus erythomatosus(SLE),and 2 into antineutrophil cytoplasmic antibodies-associated vasculitis(AAV),1 into primary Sjgren's syndrome(pSS),and 2 into rheumatoid arthritis(RA) at one to six years after diagnosis of MCTD.The patients who initially manifested as alopecia,proteinuria,thrombocytopenia,low complement were more likely to develop into SLE.Conclusion:MCTD can develop into various autoimmune diseases,such as SLE,pSS,RA,AAV.Some clinical features can probably predict future outcomes.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期270-274,共5页 Journal of Peking University:Health Sciences
关键词 混合性结缔组织病 病理状态 体征和症状 治疗结果 随访研究 Mixed connective tissue disease Pathological conditions signs and symptoms Tueatment outcome Follow-up studies
  • 相关文献

参考文献20

  • 1Kasukawa R,Tojo T,Miyawaki S,et al.Preliminary diagnosticcriteria for classification of mixed connective tissue disease//Ka-sukawa R,Sharp GC,eds.Mixed connective tissue disease andanti-nuclear antibodies[M].Amsterdam:Excerpta Medica,1987:41-47.
  • 2Sharp GC,Irwin WS,Tan EM,et al.Mixed connective tissuedisease:an apparently distinct rheumatic disease syndrome associ-ated with a specific antibody to extratable nuclear antigen[J].AmJ Med,1972,52(2):148-159.
  • 3Ragnar G,Yvingd M,Inge-Margrethe G,et al.The prevalenceand incidence of mixed connective tissue disease:a national multi-centre survey of norwegian patients[J].Ann Rheum Dis,2011,70:1047-1051.
  • 4范文强,孙文萱,侯爱萍,王文翔.抗核抗体核型检测在混合性结缔组织病中的意义[J].中华实用诊断与治疗杂志,2011,25(5):515-516. 被引量:10
  • 5Venables PJW.Mixed connective tissue disease[J].Lupus,2006,15:132-137.
  • 6韩开宇,李家宁,孙铀,吕福祯.混合性结缔组织病相关性肺部病变112例临床分析[J].中国实用内科杂志,2009,29(9):827-829. 被引量:4
  • 7Bodolay E,Gaal J,Vegh J,et al.Evaluation of survival in mixedconnective tissue disease(MCTD)[J].Orv Hetil,2002,143(45):2543-2548.
  • 8Bodolay E,Szekanecz Z,Devenyi K,et al.Evaluation of intersti-tial lung disease in mixed connective tissue disease(MCTD)[J].Rheumatology(Oxford),2005,16:312-314.
  • 9杨诚,印隆林,龙武彬,蒋瑾.结缔组织病肺间质病变的高分辨CT表现及临床意义[J].实用医学影像杂志,2009,10(6):364-366. 被引量:6
  • 10Alarcon-Segovia D,Miguel V.Classication and diagnostic criteriafor mixed connective disease//Kasukawa R,Sharp GC,eds.Mixed connective tissue disease and anti-nuclear antibodies[M].Amstredam:Elsevier,1987:33-40.

二级参考文献22

  • 1杨虎天.混合性结缔组织病诊治指南(草案)[J].中华风湿病学杂志,2004,8(6):374-377. 被引量:33
  • 2陈志娥,薛雁山.结缔组织病肺部受累的高分辨力CT表现[J].国外医学(临床放射学分册),2004,27(5):299-302. 被引量:4
  • 3田成飞,李居一.高分辨CT对结缔组织病所致肺间质病变的诊断价值[J].中国实用内科杂志,2006,26(9):1359-1360. 被引量:9
  • 4Sharp GC. Diagnostic criteria for classification of MCTD [ M ]//Kasukawa R. Mixed connective tissue disease and antinuclear antibodies. Amsterdem : Elsevier, 1987:23 - 32.
  • 5Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders [ J ]. Respiration, 2008,75 ( 4 ) : 361 -371.
  • 6Devaraj A, Wells AU, Hansell DM. Computed tomographic imaging in connective tissue diseases [ J ]. Semin Respir Crit Care Med, 2007,28 (4) : 389 - 397.
  • 7Lundberg IE. The prognosis of mixed connective tissue disease [J]. Rheum Dis Clin NOrth Am,2005,31 (3) :535 -547.
  • 8Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortal.ity of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia [ J ]. Arthritis Rheum,2005,53 (4) :549 -557.
  • 9Franquet T.High-resolution CT of lung disease related to collagen vascular disease[J]. Radiol Clin North Am, 2001,39(6):1171-1187.
  • 10Bankier AA,Kiener HP,Wiesmayer MN,et al.Discrete lung involvement in systemic lupus erythematosus:CT assessment [J]. Raiology, 1995,196(3):835-840.

共引文献49

同被引文献97

引证文献16

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部